Latest revenue
$5.6M
as of 2026-03-31
Latest net income
$-798.0K
as of 2026-03-31
Net margin
-14.1%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $8.0M
- Enterprise value
- $8.0M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $2.56
- 52-wk low
- $0.47
- Beta
- —
- Shares out
- 10.5M
5-year trend
What this company does
TEM 1. DESCRIPTION OF BUSINESS. Our Company cbdMD was originally founded in 2015 as an innovative branding and marketing company with a focus on lifestyle-based brands. In December 2018 pursuant to a two-step merger (the “Mergers”), we acquired Cure Based Development LLC ("Cure Based Development”) following the passage of the United States Agricultural Improvement Act of 2018, commonly known as the “Farm Bill”, which contained a permanent declassification of cannabidiol (CBD) as a controlled substance under federal law. As a result of that transaction, we own and operate the nationally recognized CBD brand cbdMD which now represents our focus and substantially all of our revenues. Through…
AI summary unavailable — showing raw filing excerpt
Generated from YCBD's filing dated 2019-12-18
Key risks
TEM 1.A RISK FACTORS. Investing in our securities involves risks. In addition to the other information contained in this report, you should carefully consider the following risks before deciding to purchase our securities. The occurrence of any of the following risks might cause you to lose all or a part of your investment. Some statements in this report, including statements in the following risk factors, constitute forward-looking statements. Please refer to “Cautionary Statement Regarding Forward-Looking Statements” for more information regarding forward-looking statements. RISKS RELATED TO OUR OVERALL BUSINESS We have a history of losses and there are no assurances we will report…
AI summary unavailable — showing raw filing excerpt
Generated from YCBD's filing dated 2019-12-18
Profitability
Gross margin
62.4%
3.6%Operating margin
-11.3%
32.3%Net margin
-10.6%
42.7%Return on equity
-103.9%
44.8%Return on assets
-19.6%
44.0%Leverage
Debt / equity
4.31×
1.9%Long-term debt / equity
0.00×
100.0%Debt / assets
81.2%
0.4%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $5.6M | +18.8% | $-798.0K | -71.4% | -14.1% |
Q4 2025 2025-12-31 | $5.0M | -1.9% | $-283.1K | -1975.7% | -5.6% |
Q3 2025 2025-09-30 | $4.7M | -5.5% | $-695.1K | -354.9% | -14.7% |
Q2 2025 2025-06-30 | $4.6M | -11.0% | $-895.3K | -294.7% | -19.4% |
Q1 2025 2025-03-31 | $4.7M | +8.5% | $-465.7K | +84.5% | -9.8% |
Q4 2024 2024-12-31 | $5.1M | -4.9% | $15.1K | +101.5% | 0.3% |
Q3 2024 2024-09-30 | $5.0M | — | $-152.8K | — | -3.1% |
Q2 2024 2024-06-30 | $5.2M | -15.5% | $459.7K | +126.0% | 8.9% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Perfumes, Cosmetics & Other Toilet Preparations · SIC 2844
Your notes
Keep private notes on YCBD — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$1.3M
Net activity
−$1.3M
Distinct insiders
1
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns YCBD
Institutional value
$388.3K
Total shares held
520.0K
Distinct holders
15
-10 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | UBS Group AG | 164.6K | $122.2K | +154.5K (+1521.9%) | Added |
| 2 | CHAPIN DAVIS, INC. | 81.3K | $60.3K | -1 (-0.0%) | Trimmed |
| 3 | JANE STREET GROUP, LLC | 76.3K | $56.6K | +25.2K (+49.3%) | Added |
| 4 | Alesco Advisors LLC | 68.5K | $50.8K | +0 (+0.0%) | No change |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 51.1K | $37.9K | — | New |
| 6 | VANGUARD FIDUCIARY TRUST CO | 47.2K | $35.0K | — | New |
| 7 | Chicago Partners Investment Group LLC | 13.5K | $12.6K | — | New |
| 8 | COMMONWEALTH EQUITY SERVICES, LLC | 16.3K | $12.1K | +0 (+0.0%) | No change |
| 9 | BlackRock, Inc. | 1.1K | $801 | +0 (+0.0%) | No change |
| 10 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 150 | $111 | +50 (+50.0%) | Added |
| 11 | HHM Wealth Advisors, LLC | 8 | $6 | — | New |
| 12 | Golden State Wealth Management, LLC | 4 | $4 | +0 (+0.0%) | No change |
| 13 | Farther Finance Advisors, LLC | 3 | $2 | +1 (+50.0%) | Added |
| 14 | ROTHSCHILD INVESTMENT LLC | 1 | $1 | +0 (+0.0%) | No change |
| 15 | GROUP ONE TRADING LLC | 2 | $1 | +0 (+0.0%) | No change |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once YCBD's latest filing finishes processing.